Basel is the headquarters of the Roche Group and one of its most important centres of pharmaceutical research. Over 8,500 people from approximately 90 countries work in Basel, which is one of Roche`s largest sites.
Roche is an equal opportunity employer.
Principal Medical Director
Roche / Genentech are seeking a Principal Medical Director to lead late stage interactions with early stage clinical development on high priority molecules for Neurodegenerative Disorders, and to assist in due diligence and other partnering efforts related to potential assets for Neurodegeneration.
Key accountabilities are to:
Lead interactions with pRED and gRED early clinical development groups to contribute to early stage decision making with anticipation of late stage concerns
Provide subject matter expertise, clinical science support and functional representation to discussions related to molecules in discovery or molecules being assessed by Partnering
Provide input into regulatory interactions taking place for early stage molecules from a clinical science perspective
Participate in relationship building and scientific outreach in conjunction with early stage partners within the specialty disease communities, including advocacy groups and thought leaders
Assist late stage teams on special issues as needed
Who you are
You’re someone who wants to influence your own development. You’re looking for a company where you have the opportunity to pursue your interests across functions and geographies. Where a job title is not considered the final definition of who you are, but the starting point.
We are looking for a professional with an MD and/or PhD or equivalent qualification and deep experience with drug development for neurodegenerative disorders, preferably both early and late stage development. In addition you have:
12 or more years clinical trial experience (with a minimum of 8 years clinical trial experience in pharma/biotech industry)
4 or more years’ experience authoring aspects of a/or full global clinical development plan or full clinical study protocol
In-depth relevant therapeutic area experience (typically demonstrable with 4 or more years relevant experience)
Expert knowledge of Phase II – III drug development
Comprehensive understanding of product and safety profiles
In-depth knowledge of medical aspects of GCP, ICH, FDA, EMEA, NICE and other relevant guidelines and regulations